Paracetamol Half-Life Declines over Time After an Acute Overdose

Area of Science:

• Toxicology
• Pharmacokinetics
• Clinical Pharmacology

Background:

• Paracetamol (acetaminophen) poisoning is a leading cause of drug-induced liver injury globally.
• Acetylcysteine is the standard antidote, crucial for preventing paracetamol-induced hepatotoxicity.
• Observed clinical instances of decreasing paracetamol half-life during acetylcysteine therapy prompted this investigation.

Purpose of the Study:

• To investigate the pharmacokinetic changes, specifically the half-life of paracetamol, in patients treated with acetylcysteine following an acute overdose.
• To quantify the reduction in paracetamol half-life during acetylcysteine administration.

Main Methods:

• Retrospective observational study involving patients with paracetamol poisoning treated with acetylcysteine.
• Inclusion criteria: ≥3 paracetamol plasma concentrations during a single acute overdose from two Dutch hospitals.
• Paracetamol half-lives calculated using consecutive plasma samples; defined prolonged half-life thresholds (>4.0h moderate, >5.5h severe).

Main Results:

• Seventy-one overdoses from 59 patients were analyzed.
• The mean paracetamol half-life significantly decreased from 4.6 hours (initial) to 2.9 hours (subsequent) (P < 0.001).
• A substantial proportion of patients exhibited prolonged half-lives: 28% moderately (4.0-5.5h) and 37% severely (>5.5h), with significant reductions observed in all subgroups.

Conclusions:

• The study demonstrates a significant decrease in paracetamol half-life during acetylcysteine treatment.
• Repeated paracetamol concentration monitoring and half-life calculations are recommended for clinical decision-making, especially regarding the duration of acetylcysteine therapy.
• These findings may inform adjustments to current treatment guidelines for paracetamol poisoning.